Inhibition of kinin degradation on the luminal side of renal tubules reduces high blood pressure in deoxycorticosterone acetate salt-treated rats

Clinical and Experimental Pharmacology and Physiology

Volumn 27, Issue 1-2, 2000, Pages 80-87

  Nakajima, Shinichi ^a   Ito, Hiroshi ^a   Hayashi, Izumi ^a   Kuribayashi, Yoshikazu ^a   Okumura, Toshiaki ^a   Yajima, Yoshitada ^a   Katori, Makoto ^a   Majima, Masataka ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Deoxycorticosterone acetate salt; Hypertension; Kidneys; Kininase; Kinins; Urine

Indexed keywords

CAPTOPRIL; CARBOXYPEPTIDASE C; DEOXYCORTICOSTERONE ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KININ; LISINOPRIL; MEMBRANE METALLOENDOPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERTENSION; HYPOTENSION; KIDNEY CIRCULATION; KIDNEY TUBULE; MALE; NONHUMAN; PROTEIN DEGRADATION; RAT; SODIUM URINE LEVEL;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRADYKININ; CAPTOPRIL; DESOXYCORTICOSTERONE; HYPERTENSION; KIDNEY TUBULES; LACTONES; LISINOPRIL; MALE; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SODIUM; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 0033953567     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2000.03209.x     Document Type: Article

References (31)

1. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: Kallikreins, kininogens, and kininases. Pharmacol. Rev. 1992; 44: 1-80.
2. Scicli AG, Carretero OA. Renal kallikrein-kinin system. Kidney Int. 1986; 29: 120-30.
3. 3H]-bradykinin in isolated nephron segments of the rabbit. Am. J. Physiol. 1984; 246: F732-7.
4. 2 receptor in rat kidney by anti-peptide and anti-ligand antibodies. J. Histochem. Cytochem. 1995; 43: 137-18.
5. Nolly H, Scicli AG, Scicli G, Carretero OA. Characterization of a kininogenase from rat vascular tissue resembling tissue kallikrein. Circ. Res. 1985; 56: 816-21.
6. Saed GM, Carretero OA, MacDonald RJ, Scicli AG. Kallikrein messenger RNA in rat arteries and veins. Circ. Res. 1990; 67: 510-16.
7. Majima M, Katori M, Hanazuka M et al. Suppression of rat deoxycorticosterone-salt hypertension by kallikrein-kinin system. Hypertension 1991; 17: 806-13.
8. Majima M, Ueno A, Sunahara N, Katori M. Measurement of des-Phe8-Arg9-bradykinin by enzyme-immunoassay: A useful parameter of plasma kinin release. Adv. Exp. Med. Biol. 1989; 247B: 331-5.
9. Majima M, Shima C, Saito M, Kuribayashi Y, Katori M, Aoyagi T. Poststatin, a novel inhibitor of bradykinin-degrading enzymes in rat urine. Eur. J. Pharmacol. 1993; 232: 181-90.
10. Shima C, Majima M, Katori M. A stable metabolite, Arg-Pro-Pro-Gly-Phe, of bradykinin in the degradation pathway in human plasma. Jpn. J. Pharmacol. 1992; 60: 111-19.
11. Kuribayashi Y, Majima M, Katori M, Kato H. Major kininases in rat urine are neutral endopeptidase and carboxypeptidase Y-like exopeptidase. Biomed. Res. 1993; 14: 191-201.
12. Majima M, Mizogami S, Kuribayashi Y, Katori M, Oh-ishi S. Hypertension induced by a nonpressor dose of angiotensin II in kininogen-deficient rats. Hypertension 1994; 24: 111-19.
13. 86Rb uptake in weaning Dahl rats. Am. J. Hypertens. 1989; 2: 604-9.
14. Majima M, Katori M, Ogino M et al. Failure of endogenous blood kinin levels elevated by captopril to induce hypotension in normotensive and hypertensive rats: A study using a newly developed ELISA for kinin. Biomed. Res. 1996; 17: 15-25.
15. Aoyagi T, Nagai M, Ogawa K, Kojima F, Okada M, Ikeda T. Poststatin. a new inhibitor of prolyl endopeptidase. produced by Streptomyces viridochromogenes MH534-30F3. I. Taxonomy, production, isolation, physicochemical properties and biological activities. J. Antibiot. 1991; 44: 949-55.
16. Ura N, Carretero OA, Erdos EG. Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo. Kidney Int. 1987; 32: 507-13.
17. Galjart NJ, Gillemans N, Meijer D, d'Azzo A. Mouse 'protective protein'. cDNA cloning, sequence comparison, and expression. J. Biol. Chem. 1990; 265: 4678-84.
18. Jackman HL, Meltzer HY. Factors affecting determination of platelet monoamine oxidase activity. Schizophr. Bull. 1980; 6: 259-66.
19. Tan EW, Rando RR. Identification of an isoprenylated cysteine methyl ester hydrolase activity in bovine rod outer segment membranes. Biochemistry 1992; 31: 5572-8.
20. Scaloni A, Jones WM, Barra D, Pospischil M, Sassa S, Popowicz A. Acylpeptide hydrolase: Inhibitors and some active site residues of the human enzyme. J. Biol. Chem. 1992; 267: 3811-18.
21. Majima M, Kuribayashi Y, Ikeda Y et al. Diuretic and natriuretic effect of ebelactone B in anesthetized rats by inhibition of a carboxypeptidase Y-like kininase. Jpn. J. Pharmacol. 1994; 65: 79-82.
22. 2-receptor blockade facilitates deoxycorticosterone-salt hypertension. Hypertension 1993; 21: 980-4.
23. Rhaleb NE, Peng H, Alfie ME, Sheesely EG, Carretero OA. Effect of ACE inhibitor on DOCA-salt- and aortic coarctation-induced hypertension in mice. Hypertension 1999; 33: 329-34.
24. 2 receptor knockout mice. Biochem. Biophys. Res. Commun. 1996; 224: 625-30.
25. 2 receptors. Hypertension 1997; 29: 483-7.
26. Hayashi I, Hoshiko S, Makabe O, Oh-ishi S. A point mutation of alanine 163 to threonine is responsible for the defective secretion of high molecular weight kininogen by the liver of Brown Norway Katholiek rats. J. Biol. Chem. 1993; 268: 17 219-24.
27. Tomiyama H, Scicli AG, Scicli GM, Carretero O. Renal effects of Fab fragments of kinin antibodies on deoxycorticosterone acetate-salt-treated rats. Hypertension 1990; 15: 761-6.
28. Pham I, Gonzalez W, Amrani AI et al. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension. J Pharmacol. Exp. Ther. 1993; 265: 1339-47.
29. French JF, Anderson BA, Downs TR, Dage RC. Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase in rats with hypertension. J. Cardiovasc. Pharmacol. 1995; 26: 107-13.
30. Nakajima S, Majima M, Ito H, Hayashi I, Yajima Y, Katori M. Effects of neutral endopeptidase inhibitor, BP102, on the development of deoxycorticosterone acetate-salt hypertension in kininogen-deficient Brown Norway Katholiek rats. Int. J. Tissue React. 1998; 2: 45-56.
31. Nakagawa M, Nasjletti A. Plasma kinin concentration in deoxycorticosterone-salt hypertension. Hypertension 1988; 11: 411-15.